Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity

Agnes L F Chan, Wen Shin Chang, Li Min Chen, Chi Ming Lee, Chiao En Chen, Chun Mao Lin, Jau Lang Hwang

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Evodiamine (EVO), an alkaloidal compound isolated from Evodia rutaecarpa (Juss.), has been reported to affect many physiological functions. Topoisomerase inhibitors have been developed in a variety of clinical applications. In the present study, we report the topoisomerase I (TopI) inhibitory activity of EVO, which may have properties that lead to improved therapeutic benefits. EVO is able to inhibit supercoiled plasmid DNA relaxation catalyzed by TopI. Upon treatment 0̃10 μM EVO TopI was depleted in MCF-7 breast cancer cells in a concentration-dependent and time-dependent manner in 0~120 min. A K-SDS precipitation assay was performed to measure the extent of Top I-trapped chromosomal DNA. The ability of EVO to cause the formation of a TopI-DNA complex increased in a concentration-dependent manner, in that the DNA trapped increased by 24.2% in cells treated with 30 μM. The results suggest that EVO inhibits TopI by stabilizing the enzyme and DNA covalent complex.

Original languageEnglish
Pages (from-to)1342-1352
Number of pages11
JournalMolecules
Volume14
Issue number4
DOIs
Publication statusPublished - Apr 2009

Fingerprint

Type I DNA Topoisomerase
deoxyribonucleic acid
DNA
Evodia
Topoisomerase Inhibitors
plasmids
Superhelical DNA
breast
inhibitors
enzymes
cancer
evodiamine
Assays
Plasmids
Cells
Breast Neoplasms
causes
cells
Enzymes

Keywords

  • Covalent complex
  • Evodiamine
  • Topoisomerase

ASJC Scopus subject areas

  • Organic Chemistry
  • Medicine(all)

Cite this

Chan, A. L. F., Chang, W. S., Chen, L. M., Lee, C. M., Chen, C. E., Lin, C. M., & Hwang, J. L. (2009). Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity. Molecules, 14(4), 1342-1352. https://doi.org/10.3390/molecules14041342

Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity. / Chan, Agnes L F; Chang, Wen Shin; Chen, Li Min; Lee, Chi Ming; Chen, Chiao En; Lin, Chun Mao; Hwang, Jau Lang.

In: Molecules, Vol. 14, No. 4, 04.2009, p. 1342-1352.

Research output: Contribution to journalArticle

Chan, ALF, Chang, WS, Chen, LM, Lee, CM, Chen, CE, Lin, CM & Hwang, JL 2009, 'Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity', Molecules, vol. 14, no. 4, pp. 1342-1352. https://doi.org/10.3390/molecules14041342
Chan, Agnes L F ; Chang, Wen Shin ; Chen, Li Min ; Lee, Chi Ming ; Chen, Chiao En ; Lin, Chun Mao ; Hwang, Jau Lang. / Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity. In: Molecules. 2009 ; Vol. 14, No. 4. pp. 1342-1352.
@article{b4bb2f15dbae49ce9ff9fce7a0c3fd5d,
title = "Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity",
abstract = "Evodiamine (EVO), an alkaloidal compound isolated from Evodia rutaecarpa (Juss.), has been reported to affect many physiological functions. Topoisomerase inhibitors have been developed in a variety of clinical applications. In the present study, we report the topoisomerase I (TopI) inhibitory activity of EVO, which may have properties that lead to improved therapeutic benefits. EVO is able to inhibit supercoiled plasmid DNA relaxation catalyzed by TopI. Upon treatment 0̃10 μM EVO TopI was depleted in MCF-7 breast cancer cells in a concentration-dependent and time-dependent manner in 0~120 min. A K-SDS precipitation assay was performed to measure the extent of Top I-trapped chromosomal DNA. The ability of EVO to cause the formation of a TopI-DNA complex increased in a concentration-dependent manner, in that the DNA trapped increased by 24.2{\%} in cells treated with 30 μM. The results suggest that EVO inhibits TopI by stabilizing the enzyme and DNA covalent complex.",
keywords = "Covalent complex, Evodiamine, Topoisomerase",
author = "Chan, {Agnes L F} and Chang, {Wen Shin} and Chen, {Li Min} and Lee, {Chi Ming} and Chen, {Chiao En} and Lin, {Chun Mao} and Hwang, {Jau Lang}",
year = "2009",
month = "4",
doi = "10.3390/molecules14041342",
language = "English",
volume = "14",
pages = "1342--1352",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

TY - JOUR

T1 - Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity

AU - Chan, Agnes L F

AU - Chang, Wen Shin

AU - Chen, Li Min

AU - Lee, Chi Ming

AU - Chen, Chiao En

AU - Lin, Chun Mao

AU - Hwang, Jau Lang

PY - 2009/4

Y1 - 2009/4

N2 - Evodiamine (EVO), an alkaloidal compound isolated from Evodia rutaecarpa (Juss.), has been reported to affect many physiological functions. Topoisomerase inhibitors have been developed in a variety of clinical applications. In the present study, we report the topoisomerase I (TopI) inhibitory activity of EVO, which may have properties that lead to improved therapeutic benefits. EVO is able to inhibit supercoiled plasmid DNA relaxation catalyzed by TopI. Upon treatment 0̃10 μM EVO TopI was depleted in MCF-7 breast cancer cells in a concentration-dependent and time-dependent manner in 0~120 min. A K-SDS precipitation assay was performed to measure the extent of Top I-trapped chromosomal DNA. The ability of EVO to cause the formation of a TopI-DNA complex increased in a concentration-dependent manner, in that the DNA trapped increased by 24.2% in cells treated with 30 μM. The results suggest that EVO inhibits TopI by stabilizing the enzyme and DNA covalent complex.

AB - Evodiamine (EVO), an alkaloidal compound isolated from Evodia rutaecarpa (Juss.), has been reported to affect many physiological functions. Topoisomerase inhibitors have been developed in a variety of clinical applications. In the present study, we report the topoisomerase I (TopI) inhibitory activity of EVO, which may have properties that lead to improved therapeutic benefits. EVO is able to inhibit supercoiled plasmid DNA relaxation catalyzed by TopI. Upon treatment 0̃10 μM EVO TopI was depleted in MCF-7 breast cancer cells in a concentration-dependent and time-dependent manner in 0~120 min. A K-SDS precipitation assay was performed to measure the extent of Top I-trapped chromosomal DNA. The ability of EVO to cause the formation of a TopI-DNA complex increased in a concentration-dependent manner, in that the DNA trapped increased by 24.2% in cells treated with 30 μM. The results suggest that EVO inhibits TopI by stabilizing the enzyme and DNA covalent complex.

KW - Covalent complex

KW - Evodiamine

KW - Topoisomerase

UR - http://www.scopus.com/inward/record.url?scp=66349130754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349130754&partnerID=8YFLogxK

U2 - 10.3390/molecules14041342

DO - 10.3390/molecules14041342

M3 - Article

VL - 14

SP - 1342

EP - 1352

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 4

ER -